Enliven Therapeutics Inc (ELVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1996 | 12-1995 | 12-1994 | 12-1993 | 12-1992 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -116 | -9,350 | -12,920 | 3,910 | 10,740 |
| Depreciation Amortization | 6,851 | 9,130 | 7,650 | 6,440 | 4,870 |
| Other Working Capital | -2,104 | N/A | N/A | N/A | N/A |
| Other Operating Activity | 3,232 | 4,740 | 13,140 | 7,050 | 3,230 |
| Operating Cash Flow | $7,863 | $4,520 | $7,870 | $17,400 | $18,840 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,306 | N/A | N/A | N/A | N/A |
| Net Acquisitions | -2,034 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -7,871 | 7,100 | -5,370 | -16,020 | -47,950 |
| Investing Cash Flow | $-17,211 | $7,100 | $-5,370 | $-16,020 | $-47,950 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -2,589 | -560 | 260 | 180 | 27,980 |
| Financing Cash Flow | $-2,589 | $-560 | $260 | $180 | $27,980 |
| Exchange Rate Effect | 0 | N/A | N/A | N/A | 400 |
| Beginning Cash Position | 25,412 | 14,350 | 11,590 | 10,030 | 10,750 |
| End Cash Position | 13,475 | 25,410 | 14,350 | 11,590 | 10,030 |
| Net Cash Flow | $-11,937 | $11,050 | $2,760 | $1,550 | $-1,120 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,863 | 4,520 | 7,870 | 17,400 | 18,840 |
| Free Cash Flow | 7,863 | 4,520 | 7,870 | 17,400 | 18,840 |